Benjamin Scot Bergo
Director/Board Member chez HEIQ PLC
Profil
Benjamin Scot Bergo is the founder of Visus Therapeutics, Inc. (founded in 2019) where he holds the title of Chief Executive Officer & Executive Director.
He is currently a Non-Executive Director at RPS Diagnostics, Inc., HeiQ Materials AG, and HeiQ Plc.
Mr. Bergo has previously worked as a Director at Reverse Medical Corp., a Non-Executive Director at Cavitus Solutions Pty Ltd.
(2007-2011), Planet Innovation Pty Ltd.
(2015-2019), and Lumos Diagnostics Holdings Ltd.
(2012-2021).
He has also held positions as a Principal at Danaher Corp.
and Invetech Co., as well as an Investment Manager at Southmore Capital Pty Ltd.
Mr. Bergo completed his undergraduate degree at the University of Melbourne and his graduate degree at Macquarie University.
Postes actifs de Benjamin Scot Bergo
| Sociétés | Poste | Début |
|---|---|---|
| HEIQ PLC | Director/Board Member | 30/06/2014 |
HeiQ Materials AG
 HeiQ Materials AG TextilesProcess Industries HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland. | Director/Board Member | 30/10/2014 |
RPS Diagnostics, Inc.
 RPS Diagnostics, Inc. Medical SpecialtiesHealth Technology RPS Diagnostics, Inc. develops diagnostic solutions and medical instruments. Its product FebriDx is in-office test that uses a finger stick blood sample to help differentiate viral from bacterial acute respiratory infection. The company was founded by Robert P. Sambursky in 2004 and is headquartered in Sarasota, FL. | Director/Board Member | - |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Chief Executive Officer | 01/10/2019 |
Anciens postes connus de Benjamin Scot Bergo
| Sociétés | Poste | Fin |
|---|---|---|
| LUMOS DIAGNOSTICS HOLDINGS LIMITED | Director/Board Member | 01/03/2021 |
Planet Innovation Pty Ltd.
 Planet Innovation Pty Ltd. Medical SpecialtiesHealth Technology Planet Innovation Pty Ltd. is a healthtech innovation and Australian commercialization company that specializes in product development and manufacturing. The private company is based in Box Hill, AU. and has subsidiaries in the United States. It was founded in 2009 by Eduardo Vom, Sam Lanyon, Stuart Elliott, and Troy O'Callaghan, with Stuart Elliott serving as the CEO since its inception. | Director/Board Member | 01/10/2019 |
Cavitus Solutions Pty Ltd.
 Cavitus Solutions Pty Ltd. Industrial MachineryProducer Manufacturing Cavitus Solutions Pty Ltd. develops and commercializes liquid phase industrial applications of high power ultrasound technology. It specializes in applications development, engineering design, manufacture and installation of equipment in the area of HPU for new and existing liquid-phase industrial applications with a focus on industries where products such as palm oil, olive oil, dairy and soy proteins are processed. Its customers include agricultural commodities, FMCG, industrial chemicals and pharmaceutical. The company was founded by Darren M. Bates, Ned Strong, Andrew S. Yap and Richard McLoughlin in 2006 and is headquartered in North Sydney, Australia. | Director/Board Member | 01/07/2011 |
Southmore Capital Pty Ltd.
 Southmore Capital Pty Ltd. Investment ManagersFinance Southmore Capital Pty Ltd (Southmore) is a venture capital firm is founded in 2006 by Dr. Jurgen Michaelis. The firm is headquartered in Adelaide. | Private Equity Investor | - |
Reverse Medical Corp.
 Reverse Medical Corp. Electronic Equipment/InstrumentsElectronic Technology Reverse Medical Corp. develops medical devices. The company was founded by Jeffrey Valko and Michael R. Henson in 2007 and is headquartered in Irvine, CA. | Director/Board Member | - |
Formation de Benjamin Scot Bergo
| University of Melbourne | Undergraduate Degree |
| Macquarie University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DANAHER CORPORATION | Health Technology |
| LUMOS DIAGNOSTICS HOLDINGS LIMITED | Health Technology |
| HEIQ PLC | Process Industries |
| Entreprise privées | 8 |
|---|---|
Reverse Medical Corp.
Reverse Medical Corp. Electronic Equipment/InstrumentsElectronic Technology Reverse Medical Corp. develops medical devices. The company was founded by Jeffrey Valko and Michael R. Henson in 2007 and is headquartered in Irvine, CA. | Electronic Technology |
RPS Diagnostics, Inc.
RPS Diagnostics, Inc. Medical SpecialtiesHealth Technology RPS Diagnostics, Inc. develops diagnostic solutions and medical instruments. Its product FebriDx is in-office test that uses a finger stick blood sample to help differentiate viral from bacterial acute respiratory infection. The company was founded by Robert P. Sambursky in 2004 and is headquartered in Sarasota, FL. | Health Technology |
Invetech Co.
 Invetech Co. Wholesale DistributorsDistribution Services Invetech Co. distributes bearings and industrial components. The company is headquartered in Detroit, MI. | Distribution Services |
Cavitus Solutions Pty Ltd.
Cavitus Solutions Pty Ltd. Industrial MachineryProducer Manufacturing Cavitus Solutions Pty Ltd. develops and commercializes liquid phase industrial applications of high power ultrasound technology. It specializes in applications development, engineering design, manufacture and installation of equipment in the area of HPU for new and existing liquid-phase industrial applications with a focus on industries where products such as palm oil, olive oil, dairy and soy proteins are processed. Its customers include agricultural commodities, FMCG, industrial chemicals and pharmaceutical. The company was founded by Darren M. Bates, Ned Strong, Andrew S. Yap and Richard McLoughlin in 2006 and is headquartered in North Sydney, Australia. | Producer Manufacturing |
Southmore Capital Pty Ltd.
Southmore Capital Pty Ltd. Investment ManagersFinance Southmore Capital Pty Ltd (Southmore) is a venture capital firm is founded in 2006 by Dr. Jurgen Michaelis. The firm is headquartered in Adelaide. | Finance |
HeiQ Materials AG
HeiQ Materials AG TextilesProcess Industries HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland. | Process Industries |
Planet Innovation Pty Ltd.
Planet Innovation Pty Ltd. Medical SpecialtiesHealth Technology Planet Innovation Pty Ltd. is a healthtech innovation and Australian commercialization company that specializes in product development and manufacturing. The private company is based in Box Hill, AU. and has subsidiaries in the United States. It was founded in 2009 by Eduardo Vom, Sam Lanyon, Stuart Elliott, and Troy O'Callaghan, with Stuart Elliott serving as the CEO since its inception. | Health Technology |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Health Technology |
